Drug
Insulin, Asp(B28)-
Insulin, Asp(B28)- is a pharmaceutical drug with 5 clinical trials. Historical success rate of 80.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
80.0%
Based on 4 completed trials
Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
75%(3 trials)
Terminated
1(20%)
Phase Distribution
Ph not_applicable
2
40%
Ph phase_4
1
20%
Ph phase_2
2
40%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Terminated(1)
Detailed Status
Completed4
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
80.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (40.0%)
Phase 41 (20.0%)
N/A2 (40.0%)
Trials by Status
terminated120%
completed480%
Recent Activity
0 active trials
Showing 5 of 5
completednot_applicable
Hyperglycemia in Renal Transplantation
NCT01643382
terminatedphase_4
Additional Insulin for Fat and Protein in Children With Diabetes Study
NCT02680054
completednot_applicable
A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus
NCT02419859
completedphase_2
Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital
NCT02101229
completedphase_2
Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone
NCT00797823
Clinical Trials (5)
Showing 5 of 5 trials
NCT01643382Not Applicable
Hyperglycemia in Renal Transplantation
NCT02680054Phase 4
Additional Insulin for Fat and Protein in Children With Diabetes Study
NCT02419859Not Applicable
A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus
NCT02101229Phase 2
Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital
NCT00797823Phase 2
Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5